Health Trials

Infusion Reactions

2

Review clinical trials related to Infusion Reactions. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Retrospective Kinetic Safety Evaluation of an Intravenous Micellar Excipient Platform

Protocol PICO-RWE-001: The goal of this observational study is to evaluate the kinetic safety and tolerability of an investigational intravenous micellar delivery platform. Researchers will abstract medical records of individuals who previously received this infusion in a clinical setting. The main questions the study aims to answer are: What adverse events (AEs) did participants experience during or after the infusion? Did participants discontinue their infusion regimen early due to adverse events? Researchers will abstract charts from clinical exposures occurring between June 1, 2025, and April 15, 2026. Participants do not undergo any new interventions or clinic visits.

Participants needed: 625
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: PICO IV, Inc.Updated: May 29, 2026Locations: 1
Eligibility criteria

Participant must have received at least one intravenous (IV) investigational exp... [+3]

Participants whose exposures were drawn from legacy multi-use vials. [+3]

Read more
Status: Recruiting

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.

Participants needed: 9,999
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: New York Blood CenterUpdated: Apr 13, 2026Locations: 71
Eligibility criteria

Diagnosis: Patients with disorders affecting the hematopoietic system that are i... [+2]

Patients who are receiving licensed cord blood products (only) [+3]

Read more